Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of glp-1 receptor in type 1 diabetic rat hearts

0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

This study focuses on the effects of long-term renin-angiotensin system suppression and/or incretin mimetic therapies on the regulation and binding affinity of GLP-1 to its receptor in the coronary endothelium (CE) and cardiomyocytes (CMs) of type 1 diabetic male Sprague-Dawley rats. The groups assessed are normal (N), streptozotocin-induced diabetic (D), Insulin treated (DI), Exendin-4 treated (DE), Aliskiren treated (DA), cotreated with Insulin and Aliskiren (DIA) and cotreated with exendin-4 and Aliskiren (DEA). Heart perfusion with 125I-GLP-1 was performed to estimate GLP-1 binding affinity (τ=1/k-n) to its receptor in the heart. Western Blotting was assessed to determine the expression variation of GLP-1 receptor in the heart. Plasma GLP-1 levels were measured using Enzyme-Linked Immunosorbent Assay (ELISA). Diabetes decreased the τ value on CE and increased it on CMs compared to normal. The combination of Exendin-4 with Aliskiren showed a normalizing effect on the binding affinity of GLP-1 at the coronary endothelium, while at the cardiomyocyte level Exendin-4 treatment alone was the most effective. Copyright 2011 Shushan B. Artinian et al.

Cite

CITATION STYLE

APA

Artinian, S. B., Al Lafi, S. M., Boutary, S. S., Bitar, K. M., Zwainy, N. S., & Bikhazi, A. B. (2011). Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of glp-1 receptor in type 1 diabetic rat hearts. Experimental Diabetes Research, 2011. https://doi.org/10.1155/2011/489708

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free